Cresco Labs (CRLBF) Gains from Sales and Divestitures (2024 - 2025)
Cresco Labs' (CRLBF) quarterly Gains from Sales and Divestitures came in at $169000.0 in Q1 2025, up 253.64% YoY from $47789.2 in Q1 2024, and up 253.64% on a QoQ basis from -$110000.0 in Q1 2024.
Cresco Labs (CRLBF) Gains from Sales and Divestitures (2024 - 2025) Analysis & Trends
Cresco Labs (CRLBF) has 2 years of Gains from Sales and Divestitures data on file, last reported at $169000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.33 Bn | 2.15 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.15 Bn | 19.48 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.74 Bn | 11.21 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - |
| 10 | Cresco Labs | 292.94 Mn | 228.83 Mn | 86.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 169,000.00 |
| Mar 31, 2025 | 169,000.00 |
| Mar 31, 2024 | -110,000.00 |
| Mar 31, 2024 | -110,000.00 |